Search the web
Welcome, Guest
[Sign Out, My Account]

Quotes & Info
Enter Symbol(s):
e.g. YHOO, ^DJI
Symbol Lookup | Financial Search
RGDX > SEC Filings for RGDX > Form 8-K on 13-Dec-2013All Recent SEC Filings

Show all filings for RESPONSE GENETICS INC



Entry into a Material Definitive Agreement, Other Events, Financial Stateme

Item 1.01 Entry into a Material Definitive Agreement.

On December 13, 2013, Response Genetics, Inc. (the "Company") entered into an underwriting agreement (the "Underwriting Agreement") with National Securities Corporation (the "Underwriter"), pursuant to which the Underwriter agreed to purchase 4,464,443 shares of the Company's common stock (the "Shares") at the public offering price of $1.20 per share less an underwriting discount of 5%. The Shares are being offered by the Company pursuant to an effective registration statement on Form S-3 (File No. 333-171266) filed by the Company with the Securities and Exchange Commission on December 17, 2010, as amended, as supplemented by the prospectus supplement dated December 13, 2013 relating to the offering and the accompanying prospectus (the "Offering"). The Underwriter has a 45-day option to purchase up to an additional 669,666 Shares offered in the Offering at the same price to cover over-allotments, if any.

The Company has agreed to be responsible for its expenses in connection with the Offering and to reimburse the Underwriter for up to $75,000 of its expenses, including legal expenses.

The Underwriting Agreement contains customary representations and warranties and covenants relating to the Offering, including an indemnification of the Underwriter against certain liabilities under the Securities Act of 1933, as amended.

The opinion of Willkie Farr & Gallagher LLP regarding the validity of the Shares to be sold in the Offering is attached as Exhibit 5.1 to this Current Report on Form 8-K.

The foregoing description of the Offering and the Underwriting Agreement is a summary only, is not intended to be complete, and is qualified in its entirety by reference to, and incorporates by reference, the Underwriting Agreement filed as Exhibit 1.1 to this Current Report on Form 8-K.

Item 8.01 Other Events.

On December 13, 2013, the Company issued a press release announcing the pricing of the Offering, a copy of which is furnished as Exhibit 99.1 to this Current Report on Form 8-K.

Item 9.01. Financial Statements and Exhibits.

(d) Exhibits. The following exhibits are being furnished with this Current Report on Form 8-K:

Exhibit Number Document Description

1.1 Underwriting Agreement, dated December 13, 2013, by and between Response Genetics, Inc. and National Securities Corporation.

5.1 Opinion of Willkie Farr & Gallagher LLP, dated December 13, 2013.

99.1 Press Release, dated December 13, 2013, announcing the pricing of the Offering.

  Add RGDX to Portfolio     Set Alert         Email to a Friend  
Get SEC Filings for Another Symbol: Symbol Lookup
Quotes & Info for RGDX - All Recent SEC Filings
Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
SEC Filing data and information provided by EDGAR Online, Inc. (1-800-416-6651). All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Yahoo! nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing the Yahoo! site, you agree not to redistribute the information found therein.